![Gary Zweiger](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Gary Zweiger
Founder at
Fluent BioSciences, Inc.
Profile
Gary Zweiger is the founder of Fluent BioSciences, Inc. (founded in 2018) and Bioinflexion Point Partners LLC (founded in 2013).
At Bioinflexion Point Partners LLC, he held the title of Managing Director from 2013 to 2020.
Dr. Zweiger's former jobs include Senior Director-Business Development at Affymetrix, Inc., Principal at Agilent Technologies, Inc., Investor/Adviser at Akadeum Life Sciences, Inc. from 2017 to 2019, Vice President-Business Development at Bionano Genomics, Inc., Principal at Applied Biosystems, Inc., Vice President & Business Development at Moleculo, Inc. from 2012 to 2013, Operating Partner at Cota Capital Management LLC in 2022, and Advisory Board Member at Blueprint Genetics Oy from 2015 to 2020.
Dr. Zweiger obtained his undergraduate degree from Stanford University in 1986 and his doctorate degree in 1993.
Gary Zweiger active positions
| Companies | Position | Start |
|---|---|---|
Fluent BioSciences, Inc.
 Fluent BioSciences, Inc. Miscellaneous Commercial ServicesCommercial Services Develops differentiated single-cell technology products | Founder | 2017-12-31 |
Former positions of Gary Zweiger
| Companies | Position | End |
|---|---|---|
Cota Capital Management LLC
 Cota Capital Management LLC Investment ManagersFinance Cota Capital seeks investment opportunities in public and private companies located in the United States. The firm focuses on the modern enterprise technology sectors. It participates in seed, early and later stage capital requirements. | Private Equity Investor | 2022-07-31 |
Bioinflexion Point Partners LLC
 Bioinflexion Point Partners LLC Financial ConglomeratesFinance Provides investment services | Founder | 2020-05-31 |
Blueprint Genetics Oy
 Blueprint Genetics Oy BiotechnologyHealth Technology Provides genetic diagnostics and clinical interpretation of hereditary diseases | Director/Board Member | 2019-12-31 |
Akadeum Life Sciences, Inc.
 Akadeum Life Sciences, Inc. Medical/Nursing ServicesHealth Services Provides diagnostics services | Consultant / Advisor | 2018-12-31 |
Moleculo, Inc.
 Moleculo, Inc. Miscellaneous Commercial ServicesCommercial Services Develops novel DNA sequencing method that provides very long and accurate reads | Sales & Marketing | 2012-12-31 |
Training of Gary Zweiger
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
94
1st degree connections
11
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 11 |
|---|---|
Affymetrix, Inc.
 Affymetrix, Inc. Medical SpecialtiesHealth Technology Develops, manufactures and sells products and services for genetic analysis | Health Technology |
Agilent Technologies, Inc.
 Agilent Technologies, Inc. Medical SpecialtiesHealth Technology Engages in life sciences, diagnostics and applied chemical markets | Health Technology |
Akadeum Life Sciences, Inc.
Akadeum Life Sciences, Inc. Medical/Nursing ServicesHealth Services Provides diagnostics services | Health Services |
Stanford University
 Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Bionano Genomics, Inc.
 Bionano Genomics, Inc. BiotechnologyHealth Technology Develops technologies for analysis of large biological molecules | Health Technology |
Applied Biosystems, Inc.
 Applied Biosystems, Inc. Medical SpecialtiesHealth Technology Manufactures genomics and proteomics related research instruments | Health Technology |
Moleculo, Inc.
Moleculo, Inc. Miscellaneous Commercial ServicesCommercial Services Develops novel DNA sequencing method that provides very long and accurate reads | Commercial Services |
Cota Capital Management LLC
Cota Capital Management LLC Investment ManagersFinance Cota Capital seeks investment opportunities in public and private companies located in the United States. The firm focuses on the modern enterprise technology sectors. It participates in seed, early and later stage capital requirements. | Finance |
Blueprint Genetics Oy
Blueprint Genetics Oy BiotechnologyHealth Technology Provides genetic diagnostics and clinical interpretation of hereditary diseases | Health Technology |
Bioinflexion Point Partners LLC
Bioinflexion Point Partners LLC Financial ConglomeratesFinance Provides investment services | Finance |
Fluent BioSciences, Inc.
Fluent BioSciences, Inc. Miscellaneous Commercial ServicesCommercial Services Develops differentiated single-cell technology products | Commercial Services |
- Stock Market
- Insiders
- Gary Zweiger
